Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 138

Sort by

Sort Order Select

Journal Articles

Improved Genetic Characterization of Aggressive B-Cell Lymphoma at Diagnosis Using Next-Generation Sequencing

Mariana Bastos-Oreiro, Ismael De La Iglesia, Maria Chicano, Marina Gomez Llobell, Francisco Diaz Crespo, Paula Fernández Caldas-González, Juan Carlos Triviño, Raquel Fernandez, Ramon Garcia-Sanz, Ismael Buño, Carolina Martinez-Laperche

Blood (2024) 144 (Supplement 1): 6229.

https://doi.org/10.1182/blood-2024-208216

Published: 2024

Journal Articles

Upfront CPX-351 Induction at 8 Spanish Hospital. Efficacy of CPX-351 in Everyday Clinical Practice and Increased Insight into Its Use in Younger Adults

Manuel Jorge Fernández Villalobos, Javier Ortiz, Angela Figuera Alvarez, Almudena De Laiglesia, Carlos De Miguel, Virginia Pradillo Fernandez, Jordi Esteve, Marina Diaz Beya, Marta Polo, Mayte Olave, Maria del Mar Moles, Amparo Pimentel, Ramon Garcia-Sanz, Gabriela Rodriguez Macias

Blood (2024) 144 (Supplement 1): 6034.

https://doi.org/10.1182/blood-2024-202036

Published: 2024

Journal Articles

BONE Marrow Chimerism and Measurable Residual Disease Analysis Interplay: Impact on Prognosis of ACUTE Myeloid Leukemia Undergoing STEM Celltransplatation

Manuel Jorge Fernández Villalobos, Ignacio Alberto Gomez Centurion Luna, Paula Fernández-Caldas, Rebeca Bailen, Pablo Silva, Lucia Castilla Garcia, Ana Perez-Corral, Carolina Martinez-Laperche, Ramon Garcia-Sanz, Mi Kwon

Blood (2024) 144 (Supplement 1): 7447.

https://doi.org/10.1182/blood-2024-210898

Published: 2024

Journal Articles

Molecular Tumor Burden and Clonal Evolution As Factors Associated with Early Progression in Large B-Cell Lymphomas Treated with CAR-T Therapy

Carolina Martinez-Laperche, Gonzalo Del Campo-Balguerias, Ismael De La Iglesia San Sebastián, Juan Carlos Triviño, Francisco Diaz Crespo, Rebeca Bailen, Raquel Fernandez-Gonzalez, Sara Fernandez-de Córdoba, Ana Jiménez Ubieto, Alejandro Martín-Muñoz, Paula Fernández Caldas-González, Ignacio Gómez-Centurión, Mi Kwon, Javier Anguita, Ramon García-Sanz, Ismael Buño, Mariana Bastos-Oreiro

Blood (2024) 144 (Supplement 1): 2044.

https://doi.org/10.1182/blood-2024-209913

Published: 2024

Journal Articles

Transcriptomic Signatures of T and CAR T Cells Aspredictors of Treatment Outcomes Inrelapsed/Refractory Large Diffuse B Cell Lymphoma

Ismael De La Iglesia San Sebastián, Sara Fernández de Córdoba-Oñate, Mariana Bastos-Oreiro, Raquel Fernández González, Javier Anguita, Ignacio Gómez-Centurión, Rebeca Bailen, Mi Kwon, Ramon Garcia-Sanz, Ismael Buño, Carolina Martinez-Laperche

Blood (2024) 144 (Supplement 1): 7150.

https://doi.org/10.1182/blood-2024-207145

Published: 2024

Journal Articles

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

Pilar Lancho Lavilla, Miguel Lopez-Esteban, Javier Ortiz-Alonso, Gracia Fajardo-Tórtola, Patricia Font Lopez, Marina Gomez Llobell, Jose Antonio Serra Resach, Ana Perez-Corral, Isabel Regalado Artamendi, Mónica Ballesteros Andrés, Carolina Martinez-Laperche, Gloria Figaredo Garcia-Mina, Raquel Fernández González, Carlos Jiménez, Diego Conde Royo, Cristina Pascual Izquierdo, María Teresa Vidán, Ramon García-Sanz, Gabriela Rodriguez Macias

Blood (2024) 144 (Supplement 1): 5050.

https://doi.org/10.1182/blood-2024-203872

Published: 2024

Journal Articles

Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia

Lucia Castilla Garcia, Rebeca Bailen, Ignacio Alberto Gomez Centurion Luna, Paula Fernández-Caldas, Pablo Silva De Tena, Carolina Martinez-Laperche, Javier Anguita, Ramon Garcia-Sanz, Mi Kwon

Blood (2024) 144 (Supplement 1): 4889.

https://doi.org/10.1182/blood-2024-210237

Published: 2024

Journal Articles

Predictive Value of Liver Sitffness Measurement for Early Diagnosis of Veno-Occlusive Disease and Final Stem-Cell Outcomes

Manuel Jorge Fernández Villalobos, Rebeca Bailen, Ignacio Alberto Gomez Centurion Luna, Pablo Silva, Lucia Castilla Garcia, Paula Fernández-Caldas, Sonia Alonso, Adriana Ahumada, Carlos Iniesta, Rafael Bañares, Ramon Garcia-Sanz, Mi Kwon

Blood (2024) 144 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2024-209475

Published: 2024

Journal Articles

Multiomic Characterization of Clonotypic B Cells in Patients with Monoclonal Gammopathies

Blood (2024) 144 (Supplement 1): 1879.

https://doi.org/10.1182/blood-2024-201435

Published: 2024

Journal Articles

Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331

Ramon Garcia-Sanz, Anna Sureda Balari, Eva Domingo Domenech, Francisco Javier Capote Huelva, Antonio Gutierrez, Antonia Rodriguez Izquierdo, Marta Grande De Domingo, Lourdes Baeza

Blood (2024) 144 (Supplement 1): 2376.

https://doi.org/10.1182/blood-2024-193585

Published: 2024

Journal Articles

Real-World Management Patterns of Acute Toxicity Following Bispecific Antibody Therapy for Patients with B-Cell Lymphoma - the Geltamo (Spanish Lymphoma Group) Experience

Blood (2024) 144 (Supplement 1): 3109.

https://doi.org/10.1182/blood-2024-207895

Published: 2024

Journal Articles

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Blood (2024) 144 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2024-197940

Published: 2024

Journal Articles

Exploring the Cell-Free Transcriptome As Biomarker Source in IgM Gammopathies: New Insights from the Fondazione Italiana Linfomi “BIO-WM” Trial

Blood (2024) 144 (Supplement 1): 3297.

https://doi.org/10.1182/blood-2024-198382

Published: 2024

Journal Articles

Optimal Timing for Response Assessment in Acute Myeloid Leukemia Patients Treated with CPX-351 Induction: Real World Experience from 8 Spanish Hospitals

Manuel Jorge Fernández Villalobos, Javier Ortiz, Angela Figuera Alvarez, Carlos De Miguel, Almudena De Laiglesia, Virginia Pradillo Fernandez, Marina Diaz Beya, Jordi Esteve, Marta Polo, Mayte Olave, Maria del Mar Moles, Amparo Pimentel, Ramon Garcia-Sanz, Gabriela Rodriguez Macias

Blood (2024) 144 (Supplement 1): 4285.

https://doi.org/10.1182/blood-2024-209528

Published: 2024

Journal Articles

Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008

David Lavie, John Timmerman, Ramón García-Sanz, Won Seog Kim, Tae Min Kim, Abraham Avigdor, Daan Dierickx, Deepa Jagadeesh, Daniel L. Molin, Muhit Ozcan, Omur Gokmen Sevindik, Hayder Saeed, Yulia Sidi, Pallavi Pillai, Patricia Marinello, Alex F. Herrera

Blood (2023) 142 (Supplement 1): 3082.

https://doi.org/10.1182/blood-2023-182119

Published: 2023

Journal Articles

Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Receiving Ibrutinib on the Phase 3 ASPEN Study ≥1 Year After Transitioning to Zanubrutinib

Ramon Garcia-Sanz, Roger Owen, Wojciech Jurczak, Meletios A. Dimopoulos, Helen McCarthy, Gavin Cull, Stephen Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cleary Cohen, Constantine S. Tam

Blood (2023) 142 (Supplement 1): 3043.

https://doi.org/10.1182/blood-2023-174294

Published: 2023

Journal Articles

Prognostic Factors and Treatment Strategy in Patients with Hodgkin Lymphoma and HIV Infection Treated with ABVD and CART: A Retrospective Study from Spanish Group Geltamo

Maria Huguet, Aleix Méndez, Blanca Sanchez-Gonzalez, Mariana Bastos-Oreiro, Ramon Garcia-Sanz, Samuel Romero, María-Jesús Vidal-Manceñido, Antonio Gutiérrez, Paola Villafuerte Gutierrez, Ana Garcia Noblejas, Gustavo Tapia, Juan-Manuel Sancho, Josep-Maria Ribera, José-Tomás Navarro

Blood (2023) 142 (Supplement 1): 4454.

https://doi.org/10.1182/blood-2023-189756

Published: 2023

Journal Articles

Analysis of Peripheral Blood and Bone Marrow Residual Disease Dynamics during Intensive Treatment and Maintenance in Patients with Multiple Myeloma Included in the GEM12MENOS65 and GEM14MAIN Clinical Trials

Blood (2023) 142 (Supplement 1): 3324.

https://doi.org/10.1182/blood-2023-184837

Published: 2023

Journal Articles

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

Blood (2023) 142 (Supplement 1): 4511.

https://doi.org/10.1182/blood-2023-186952

Published: 2023

Journal Articles

Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Blood (2023) 142 (Supplement 1): 4406.

https://doi.org/10.1182/blood-2023-189581

Published: 2023

NARROW

Improved Genetic Characterization of Aggressive B-Cell Lymphoma at Diagnosis Using Next-Generation Sequencing

Upfront CPX-351 Induction at 8 Spanish Hospital. Efficacy of CPX-351 in Everyday Clinical Practice and Increased Insight into Its Use in Younger Adults

BONE Marrow Chimerism and Measurable Residual Disease Analysis Interplay: Impact on Prognosis of ACUTE Myeloid Leukemia Undergoing STEM Celltransplatation

Molecular Tumor Burden and Clonal Evolution As Factors Associated with Early Progression in Large B-Cell Lymphomas Treated with CAR-T Therapy

Transcriptomic Signatures of T and CAR T Cells Aspredictors of Treatment Outcomes Inrelapsed/Refractory Large Diffuse B Cell Lymphoma

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia

Predictive Value of Liver Sitffness Measurement for Early Diagnosis of Veno-Occlusive Disease and Final Stem-Cell Outcomes

Multiomic Characterization of Clonotypic B Cells in Patients with Monoclonal Gammopathies

Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331

Real-World Management Patterns of Acute Toxicity Following Bispecific Antibody Therapy for Patients with B-Cell Lymphoma - the Geltamo (Spanish Lymphoma Group) Experience

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Exploring the Cell-Free Transcriptome As Biomarker Source in IgM Gammopathies: New Insights from the Fondazione Italiana Linfomi “BIO-WM” Trial

Optimal Timing for Response Assessment in Acute Myeloid Leukemia Patients Treated with CPX-351 Induction: Real World Experience from 8 Spanish Hospitals

Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008

Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Receiving Ibrutinib on the Phase 3 ASPEN Study ≥1 Year After Transitioning to Zanubrutinib

Prognostic Factors and Treatment Strategy in Patients with Hodgkin Lymphoma and HIV Infection Treated with ABVD and CART: A Retrospective Study from Spanish Group Geltamo

Analysis of Peripheral Blood and Bone Marrow Residual Disease Dynamics during Intensive Treatment and Maintenance in Patients with Multiple Myeloma Included in the GEM12MENOS65 and GEM14MAIN Clinical Trials

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only